Motor Unit Abnormalities After Experimentally Induced Sensitization
NCT ID: NCT04361149
Last Updated: 2020-04-24
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
PHASE4
Total Enrollment
23 participants
Study Classification
INTERVENTIONAL
Study Start Date
2019-10-01
Study Completion Date
2020-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Central sensitization is a condition that represents a cascade of neurological adaptations, resulting in an amplification of nociceptive responses from noxious and non-noxious stimuli. This phenomenon presents itself in a vast majority of chronic pain syndromes. Previous evidence has shown that central sensitization results in afferent nociceptor and dorsal horn abnormalities; however, a link between whether this abnormality translates into motor output and more specifically, ventral horn abnormalities, needs to be further explored. Twenty participants were recruited and either a topical capsaicin or a placebo topical cream was applied to their back to induce a transient state of sensitization. Surface electromyography(sEMG) and intramuscular electromyography(iEMG) were used to record motor unit activity from the trapezius and infraspinatus muscles before and after application of capsaicin/placebo. Motor unit recruitment and variability were analyzed in the sEMG and iEMG respectively
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Capsaicin-induced Pain on Homeostatic Plasticity in Healthy Human Participants
NCT04485689
Healthy
UNKNOWN
NA
Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol
NCT03132142
Pain
Pruritus
Neuropathic Pain
+1 more
UNKNOWN
NA
A Human Experimental Model for Neuropathic Pain Using Combined Application of Capsaicin and Local Anesthetics
NCT01540877
Ipsi- and Contralateral Hypoesthesia
COMPLETED
NA
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream
NCT01883102
Pain
COMPLETED
PHASE1
Capsaicin-induced Muscle Pain in Humans
NCT02377180
Healthy
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Central sensitization describes a state of neuronal hyper-excitability in the central nervous system that may occur due to malfunction of spinal and supraspinal pain facilitatory and inhibitory circuits resulting in amplification of somatosensorial responses. Beyond somatosensorial changes, alteration in motor function can also be present with pain, and may be a reflex of neuromuscular function impairment. A normal afferent input and normal central processing circuitry is essential to deliver normal efferent output. However, the influence of the changes that occur within the dorsal horn on the ventral horn remain largely ill defined.
Motor unit assessment is crucial in evaluating diseases and abnormalities within the ventral horn. Activity of the ventral horn, where anterior horn cells reside, is very important for motor unit activation. Surface EMG (sEMG) and intramuscular EMG (iEMG) can be used to assess the neural drive to muscles, by recording motor units to understand the effects of central sensitization on motor control and the ventral horn. Based on Henneman's size principle, motor units should be recruited in the same order, with smaller units being recruited first. This principle presents an opportunity to investigate if central sensitization creates abnormalities on the motor unit level.
Previously, central sensitization has been induced in healthy subjects to examine its neurophysiological effects via capsaicin. Capsaicin, a chilli pepper extract, can be used to effectively induce experimental transient states of central sensitization. The presence of expanded sensorial responses and the involvement of the spinal nociceptive system post capsaicin have been largely tested by means of quantitative sensory testing methods and electromyography (EMG).
Despite the usefulness of experimental capsaicin to better understand the sensorial abnormalities, its impact on motor function and motor unit recruitment are lesser studied. Evidence suggests that nociceptive input by peripheral capsaicin exerts a centrally-mediated inhibitory effect on motor function. A decrease in root mean squared (RMS) amplitude during exercise at the time of peak sensitization was measured by needle EMG. However, the effect that capsaicin-induced sensitization has on individual motor units or on their recruitment patterns has not been previously examined.
The purpose of this study was to determine whether topical capsaicin-induced sensitization has any influence on ventral horn activity. We hypothesize that capsaicin induces a change in individual motor unit activity, as well as the recruitment pattern of many motor units, and may affect motor unit activity at different segmental levels from the level of capsaicin application.
Participants:
Twenty-three healthy participants, age between 20-70 years old, with no direct trauma to cervicothoracic region within the past 30 days, no past medical history of inflammatory disorders as rheumatoid arthritis, no neurodegenerative disorders such as Parkinson's disease nor motor neurone diseases as amyotrophic lateral sclerosis, or other neuromuscular disorder were recruited for this study. Also, included subjects had a normal body mass index (18.5 - 24.9) and had a pain visual analogue scale (VAS) below 3 indicating low pain severity. Since prevalence of neck pain in the general population is high, mild pain or aches are not necessarily related to an abnormality of the underlying muscle. Participants had to be able to communicate in English. Participants were excluded if they had persistent pain for more than 3 months.
Experimental Protocol:
An initial screening was performed to assess eligibility in the study. Each participant was seated upright with their hands comfortably on their lap and asked to relax their neck and shoulder muscles. The physician member of the research team then assessed the patients' pain intensity by visual analogue scale (VAS). VAS ranges from 0 to 100 mm which 0 mm reflecting no pain at all and 100 mm representing the worst imaginable pain. Following this, brush allodynia, a clinical technique used to identify pain due to a stimulus that does not normally provoke pain, was performed to confirm presence of central sensitization. To map out borders of secondary allodynia, subjects were instructed to recognize a distinct alteration in the sensation perception such as increased burning, intense pricking, or an unpleasant sensation, and that location was marked. Brush allodynia score (BAS) was calculated as the distance between the farthest points marked on the superior and inferior axis multiplied by the distance between the farthest points marked on the medial and lateral axis as previously described by Cavallone et. al. The VAS and the presence of central sensitization by means of BAS were assessed at baseline (pre) before the induction of sensitization and twenty minutes after (post).
Upon successful screening of inclusion and exclusion criteria, participants had their left side area of skin (overlying the upper trapezius and infraspinatus muscles) cleansed with alcohol preparation pads and water. The skin was abraded with '3M Red Dot' abrasive strips before application of the surface electromyogram (Trigno Galileo sensors, Delsys Inc.). Electrodes were placed in 4 areas: the muscle belly of the upper trapezius, and the infraspinatus, as well as reference electrodes on C7 and the acromion. These electrodes were 4 channel EMG sensors and had their signals filtered from 20 - 450 Hz. The sEMG recordings were wirelessly transmitted to the Trigno base station, which relays and compiles the data to Neuromap (Delsys Inc.) for signal analysis. A monopolar needle electrode was inserted into the upper fibers of trapezius muscle and its reference was placed at the mid-clavicle point. Using this setup intramuscular recordings of single motor units were performed using an Excaliber, Natus Medical clinical electrodiagnostic machine.
Electromyograms recordings before application of intervention
Participants were instructed to perform horizontal shoulder abductions from 0° to 90° and then from 90° to 0° for 1 minute. The study subject was verbally cued to move their arm every 2 seconds. sEMGs were recorded during this time. Upon completion of this task, a monopolar intramuscular needle electrode was placed directly into the upper trapezius muscle. Participants were then instructed to gently contract their trapezius muscle by shrugging their shoulder, enough to recruit only the first motor unit in that region. Visual feedback of the signal was given to the subject to ensure that only the first motor unit was activated for the movement. The signal from this motor unit was then optimized for initial deflection from baseline and amplitude characteristics before recordings were made. iEMG recordings were recorded for 30 seconds at a sampling frequency of 6 kHz.
Application of intervention
Participants received either a dose of 2.5 ml (75µg/ml) capsaicin cream (treatment, Zostrix brand) or skin lotion (placebo) which was inert and caused no sensitization effects. Participants were also blinded to the delivered treatment, using concealed containers for the creams. The location of application was a 10 cm by 10 cm square on trapezius muscle which extended from T3 to T8 on the left side that all recordings were conducted.
After collection of the baseline sEMG and iEMG recordings, a trained medical professional applied the capsaicin / placebo cream directly to the region of skin in a standardized 10 cm x 10 cm square at the spinal levels T3-T8, to sensitize the nociceptive afferents within that region. A twenty-minute waiting period was used to enable the sensitizing effects of capsaicin to take effect.
Electromyograms recordings after application of intervention
To confirm the presence of central sensitization, brush allodynia was used to detect mechanical allodynia outside the region of the primary nociception - region of topical placement - which is the region of secondary allodynia. Upon confirmation of central sensitization, in participants with application of topical capsaicin, participants were entered into the experimental arm of the study.
Motor unit assessment is crucial in evaluating diseases and abnormalities within the ventral horn. Activity of the ventral horn, where anterior horn cells reside, is very important for motor unit activation. Surface EMG (sEMG) and intramuscular EMG (iEMG) can be used to assess the neural drive to muscles, by recording motor units to understand the effects of central sensitization on motor control and the ventral horn. Based on Henneman's size principle, motor units should be recruited in the same order, with smaller units being recruited first. This principle presents an opportunity to investigate if central sensitization creates abnormalities on the motor unit level.
Previously, central sensitization has been induced in healthy subjects to examine its neurophysiological effects via capsaicin. Capsaicin, a chilli pepper extract, can be used to effectively induce experimental transient states of central sensitization. The presence of expanded sensorial responses and the involvement of the spinal nociceptive system post capsaicin have been largely tested by means of quantitative sensory testing methods and electromyography (EMG).
Despite the usefulness of experimental capsaicin to better understand the sensorial abnormalities, its impact on motor function and motor unit recruitment are lesser studied. Evidence suggests that nociceptive input by peripheral capsaicin exerts a centrally-mediated inhibitory effect on motor function. A decrease in root mean squared (RMS) amplitude during exercise at the time of peak sensitization was measured by needle EMG. However, the effect that capsaicin-induced sensitization has on individual motor units or on their recruitment patterns has not been previously examined.
The purpose of this study was to determine whether topical capsaicin-induced sensitization has any influence on ventral horn activity. We hypothesize that capsaicin induces a change in individual motor unit activity, as well as the recruitment pattern of many motor units, and may affect motor unit activity at different segmental levels from the level of capsaicin application.
Participants:
Twenty-three healthy participants, age between 20-70 years old, with no direct trauma to cervicothoracic region within the past 30 days, no past medical history of inflammatory disorders as rheumatoid arthritis, no neurodegenerative disorders such as Parkinson's disease nor motor neurone diseases as amyotrophic lateral sclerosis, or other neuromuscular disorder were recruited for this study. Also, included subjects had a normal body mass index (18.5 - 24.9) and had a pain visual analogue scale (VAS) below 3 indicating low pain severity. Since prevalence of neck pain in the general population is high, mild pain or aches are not necessarily related to an abnormality of the underlying muscle. Participants had to be able to communicate in English. Participants were excluded if they had persistent pain for more than 3 months.
Experimental Protocol:
An initial screening was performed to assess eligibility in the study. Each participant was seated upright with their hands comfortably on their lap and asked to relax their neck and shoulder muscles. The physician member of the research team then assessed the patients' pain intensity by visual analogue scale (VAS). VAS ranges from 0 to 100 mm which 0 mm reflecting no pain at all and 100 mm representing the worst imaginable pain. Following this, brush allodynia, a clinical technique used to identify pain due to a stimulus that does not normally provoke pain, was performed to confirm presence of central sensitization. To map out borders of secondary allodynia, subjects were instructed to recognize a distinct alteration in the sensation perception such as increased burning, intense pricking, or an unpleasant sensation, and that location was marked. Brush allodynia score (BAS) was calculated as the distance between the farthest points marked on the superior and inferior axis multiplied by the distance between the farthest points marked on the medial and lateral axis as previously described by Cavallone et. al. The VAS and the presence of central sensitization by means of BAS were assessed at baseline (pre) before the induction of sensitization and twenty minutes after (post).
Upon successful screening of inclusion and exclusion criteria, participants had their left side area of skin (overlying the upper trapezius and infraspinatus muscles) cleansed with alcohol preparation pads and water. The skin was abraded with '3M Red Dot' abrasive strips before application of the surface electromyogram (Trigno Galileo sensors, Delsys Inc.). Electrodes were placed in 4 areas: the muscle belly of the upper trapezius, and the infraspinatus, as well as reference electrodes on C7 and the acromion. These electrodes were 4 channel EMG sensors and had their signals filtered from 20 - 450 Hz. The sEMG recordings were wirelessly transmitted to the Trigno base station, which relays and compiles the data to Neuromap (Delsys Inc.) for signal analysis. A monopolar needle electrode was inserted into the upper fibers of trapezius muscle and its reference was placed at the mid-clavicle point. Using this setup intramuscular recordings of single motor units were performed using an Excaliber, Natus Medical clinical electrodiagnostic machine.
Electromyograms recordings before application of intervention
Participants were instructed to perform horizontal shoulder abductions from 0° to 90° and then from 90° to 0° for 1 minute. The study subject was verbally cued to move their arm every 2 seconds. sEMGs were recorded during this time. Upon completion of this task, a monopolar intramuscular needle electrode was placed directly into the upper trapezius muscle. Participants were then instructed to gently contract their trapezius muscle by shrugging their shoulder, enough to recruit only the first motor unit in that region. Visual feedback of the signal was given to the subject to ensure that only the first motor unit was activated for the movement. The signal from this motor unit was then optimized for initial deflection from baseline and amplitude characteristics before recordings were made. iEMG recordings were recorded for 30 seconds at a sampling frequency of 6 kHz.
Application of intervention
Participants received either a dose of 2.5 ml (75µg/ml) capsaicin cream (treatment, Zostrix brand) or skin lotion (placebo) which was inert and caused no sensitization effects. Participants were also blinded to the delivered treatment, using concealed containers for the creams. The location of application was a 10 cm by 10 cm square on trapezius muscle which extended from T3 to T8 on the left side that all recordings were conducted.
After collection of the baseline sEMG and iEMG recordings, a trained medical professional applied the capsaicin / placebo cream directly to the region of skin in a standardized 10 cm x 10 cm square at the spinal levels T3-T8, to sensitize the nociceptive afferents within that region. A twenty-minute waiting period was used to enable the sensitizing effects of capsaicin to take effect.
Electromyograms recordings after application of intervention
To confirm the presence of central sensitization, brush allodynia was used to detect mechanical allodynia outside the region of the primary nociception - region of topical placement - which is the region of secondary allodynia. Upon confirmation of central sensitization, in participants with application of topical capsaicin, participants were entered into the experimental arm of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Central Sensitisation
Motor Disorders
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
A randomized placebo controlled trial using 2 treatments: 1) placebo cream 2) capsaicin cream (0.075%) (Zostrix HP)
Primary Study Purpose
BASIC_SCIENCE
Blinding Strategy
SINGLE
Participants
The participants were blinded by the cream treatment given. Both creams were in a concealed, blank, container
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo Topical
The cream was a lipobase cream, applied topically to the participants upper back, on their left side.
Group Type
PLACEBO_COMPARATOR
Delsys Trigno Galileo System
Intervention Type
DEVICE
A wireless surface EMG device. The sensors will be placed on the trapezius and the infraspinatus muscle, and a recording will be performed.
Excaliber, Natus Medical
Intervention Type
DEVICE
Intramuscular EMG machine. The intramuscular electrode will be inserted into the trapezius and a recording will be performed.
Placebo Cream
Intervention Type
OTHER
Placebo cream will be administered as a topical skin cream
Capsaicin Topical
Capsaicin Cream (0.075%), applied topically to the participants upper back, on their left side.
Group Type
ACTIVE_COMPARATOR
Capsaicin Topical Cream (0.075%)
Intervention Type
DRUG
Capsaicin cream will be administered as a topical skin cream
Delsys Trigno Galileo System
Intervention Type
DEVICE
A wireless surface EMG device. The sensors will be placed on the trapezius and the infraspinatus muscle, and a recording will be performed.
Excaliber, Natus Medical
Intervention Type
DEVICE
Intramuscular EMG machine. The intramuscular electrode will be inserted into the trapezius and a recording will be performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capsaicin Topical Cream (0.075%)
Capsaicin cream will be administered as a topical skin cream
Intervention Type
DRUG
Delsys Trigno Galileo System
A wireless surface EMG device. The sensors will be placed on the trapezius and the infraspinatus muscle, and a recording will be performed.
Intervention Type
DEVICE
Excaliber, Natus Medical
Intramuscular EMG machine. The intramuscular electrode will be inserted into the trapezius and a recording will be performed.
Intervention Type
DEVICE
Placebo Cream
Placebo cream will be administered as a topical skin cream
Intervention Type
OTHER
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Zostrix HP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subject with a normal body mass index (18.5 - 24.9)
* a pain visual analogue scale (VAS) below 3 indicating low pain severity
* a pain visual analogue scale (VAS) below 3 indicating low pain severity
Exclusion Criteria
* medical history of inflammatory disorders as rheumatoid arthritis
* neurodegenerative disorders such as Parkinson's disease
* motor neurone diseases as amyotrophic lateral sclerosis, or other neuromuscular disorder
* neurodegenerative disorders such as Parkinson's disease
* motor neurone diseases as amyotrophic lateral sclerosis, or other neuromuscular disorder
Minimum Eligible Age
20 Years
Maximum Eligible Age
70 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Toronto Rehabilitation Institute
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dinesh Kumbhare
Affiliate Scientist
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dinesh Kumbahre, PhD
Role: PRINCIPAL_INVESTIGATOR
Toronto Rehabilitation Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto Rehabilitation Institute
Toronto, Ontario, Canada
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Canada
References
Explore related publications, articles, or registry entries linked to this study.
Schopflocher D, Taenzer P, Jovey R. The prevalence of chronic pain in Canada. Pain Res Manag. 2011 Nov-Dec;16(6):445-50. doi: 10.1155/2011/876306.
Reference Type
BACKGROUND
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.
Reference Type
BACKGROUND
Grossschadl F, Freidl W, Rasky E, Burkert N, Muckenhuber J, Stronegger WJ. A 35-year trend analysis for back pain in Austria: the role of obesity. PLoS One. 2014 Sep 10;9(9):e107436. doi: 10.1371/journal.pone.0107436. eCollection 2014.
Reference Type
BACKGROUND
Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001 Nov;24(11):1936-40. doi: 10.2337/diacare.24.11.1936.
Reference Type
BACKGROUND
Langley PC, Ruiz-Iban MA, Molina JT, De Andres J, Castellon JR. The prevalence, correlates and treatment of pain in Spain. J Med Econ. 2011;14(3):367-80. doi: 10.3111/13696998.2011.583303. Epub 2011 May 17.
Reference Type
BACKGROUND
Duenas M, Salazar A, Ojeda B, Fernandez-Palacin F, Mico JA, Torres LM, Failde I. A nationwide study of chronic pain prevalence in the general spanish population: identifying clinical subgroups through cluster analysis. Pain Med. 2015 Apr;16(4):811-22. doi: 10.1111/pme.12640. Epub 2014 Dec 19.
Reference Type
BACKGROUND
S. D. Phillips CJ, Chronic pain: a health policy perspective.In: S. Rashiq, D. Schopflocher, P. Taenzer and E. Jonsson, Eds., Weinheim: Wiley, 2008: 41-50.
Reference Type
BACKGROUND
Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009 Sep;10(9):895-926. doi: 10.1016/j.jpain.2009.06.012.
Reference Type
BACKGROUND
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011 Mar;152(3 Suppl):S2-S15. doi: 10.1016/j.pain.2010.09.030. Epub 2010 Oct 18.
Reference Type
BACKGROUND
Sterling M, Jull G, Wright A. The effect of musculoskeletal pain on motor activity and control. J Pain. 2001 Jun;2(3):135-45. doi: 10.1054/jpai.2001.19951.
Reference Type
BACKGROUND
Hossain MZ, Unno S, Ando H, Masuda Y, Kitagawa J. Neuron-Glia Crosstalk and Neuropathic Pain: Involvement in the Modulation of Motor Activity in the Orofacial Region. Int J Mol Sci. 2017 Sep 26;18(10):2051. doi: 10.3390/ijms18102051.
Reference Type
BACKGROUND
Wallwork SB, Grabherr L, O'Connell NE, Catley MJ, Moseley GL. Defensive reflexes in people with pain - a biomarker of the need to protect? A meta-analytical systematic review. Rev Neurosci. 2017 May 24;28(4):381-396. doi: 10.1515/revneuro-2016-0057.
Reference Type
BACKGROUND
Henderson RD, McCombe PA. Assessment of Motor Units in Neuromuscular Disease. Neurotherapeutics. 2017 Jan;14(1):69-77. doi: 10.1007/s13311-016-0473-z.
Reference Type
BACKGROUND
Enoka RM. Physiological validation of the decomposition of surface EMG signals. J Electromyogr Kinesiol. 2019 Jun;46:70-83. doi: 10.1016/j.jelekin.2019.03.010. Epub 2019 Mar 21.
Reference Type
BACKGROUND
Merletti R, Farina D. Analysis of intramuscular electromyogram signals. Philos Trans A Math Phys Eng Sci. 2009 Jan 28;367(1887):357-68. doi: 10.1098/rsta.2008.0235.
Reference Type
BACKGROUND
HENNEMAN E, SOMJEN G, CARPENTER DO. FUNCTIONAL SIGNIFICANCE OF CELL SIZE IN SPINAL MOTONEURONS. J Neurophysiol. 1965 May;28:560-80. doi: 10.1152/jn.1965.28.3.560. No abstract available.
Reference Type
BACKGROUND
Torebjork HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol. 1992 Mar;448:765-80. doi: 10.1113/jphysiol.1992.sp019069.
Reference Type
BACKGROUND
W. Willis. Central sensitization and plasticity following intense noxious stimulation. In: E. Mayer and H. Raybould, Eds. Basic and clinic aspect of chronic abdominal pain. New York, NY: Elsevier, 1993: 201-207.
Reference Type
BACKGROUND
Willis WD. Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci. 2001 Mar;933:142-56. doi: 10.1111/j.1749-6632.2001.tb05821.x.
Reference Type
BACKGROUND
Frymoyer AR, Rowbotham MC, Petersen KL. Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers. J Pain. 2007 Jan;8(1):19-25. doi: 10.1016/j.jpain.2006.05.010. Epub 2006 Nov 16.
Reference Type
BACKGROUND
Gronroos M, Pertovaara A. Capsaicin-induced central facilitation of a nociceptive flexion reflex in humans. Neurosci Lett. 1993 Sep 3;159(1-2):215-8. doi: 10.1016/0304-3940(93)90837-b.
Reference Type
BACKGROUND
LaMotte RH, Lundberg LE, Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol. 1992 Mar;448:749-64. doi: 10.1113/jphysiol.1992.sp019068.
Reference Type
BACKGROUND
Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW, Jensen TS. Effects of evoked pain on the electromyogram and compound muscle action potential of the brachial biceps muscle. Muscle Nerve. 2005 Jan;31(1):25-33. doi: 10.1002/mus.20182.
Reference Type
BACKGROUND
World Medical Association,
Reference Type
BACKGROUND
WHO,
Reference Type
BACKGROUND
Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A. Assessment of pain. Br J Anaesth. 2008 Jul;101(1):17-24. doi: 10.1093/bja/aen103. Epub 2008 May 16.
Reference Type
BACKGROUND
Cavallone LF, Frey K, Montana MC, Joyal J, Regina KJ, Petersen KL, Gereau RW 4th. Reproducibility of the heat/capsaicin skin sensitization model in healthy volunteers. J Pain Res. 2013 Nov 7;6:771-84. doi: 10.2147/JPR.S53437. eCollection 2013.
Reference Type
BACKGROUND
Nawab SH, Chang SS, De Luca CJ. High-yield decomposition of surface EMG signals. Clin Neurophysiol. 2010 Oct;121(10):1602-15. doi: 10.1016/j.clinph.2009.11.092. Epub 2010 Apr 28.
Reference Type
BACKGROUND
Koh RG, Nachman AI, Zariffa J. Use of spatiotemporal templates for pathway discrimination in peripheral nerve recordings: a simulation study. J Neural Eng. 2017 Feb;14(1):016013. doi: 10.1088/1741-2552/14/1/016013. Epub 2016 Dec 21.
Reference Type
BACKGROUND
Martinez-Valdes E, Negro F, Laine CM, Falla D, Mayer F, Farina D. Tracking motor units longitudinally across experimental sessions with high-density surface electromyography. J Physiol. 2017 Mar 1;595(5):1479-1496. doi: 10.1113/JP273662.
Reference Type
BACKGROUND
Quiroga RQ, Nadasdy Z, Ben-Shaul Y. Unsupervised spike detection and sorting with wavelets and superparamagnetic clustering. Neural Comput. 2004 Aug;16(8):1661-87. doi: 10.1162/089976604774201631.
Reference Type
BACKGROUND
Ha SM, Kwon OY, Cynn HS, Lee WH, Kim SJ, Park KN. Selective activation of the infraspinatus muscle. J Athl Train. 2013 May-Jun;48(3):346-52. doi: 10.4085/1062-6050-48.2.18. Epub 2013 Feb 20.
Reference Type
BACKGROUND
Hoheisel U, Mense S, Simons DG, Yu XM. Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: a model for referral of muscle pain? Neurosci Lett. 1993 Apr 16;153(1):9-12. doi: 10.1016/0304-3940(93)90064-r.
Reference Type
BACKGROUND
Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep. 2003 Oct;7(5):355-61. doi: 10.1007/s11916-003-0034-0.
Reference Type
BACKGROUND
Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010 Oct;6(10):599-606. doi: 10.1038/nrrheum.2010.107. Epub 2010 Jul 27.
Reference Type
BACKGROUND
Umeda M, Corbin LW, Maluf KS. Preliminary investigation of absent nociceptive flexion reflex responses among more symptomatic women with fibromyalgia syndrome. Rheumatol Int. 2013 Sep;33(9):2365-72. doi: 10.1007/s00296-013-2725-0. Epub 2013 Apr 4.
Reference Type
BACKGROUND
Ziegler EA, Magerl W, Meyer RA, Treede RD. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain. 1999 Dec;122 ( Pt 12):2245-57. doi: 10.1093/brain/122.12.2245.
Reference Type
BACKGROUND
Andersson JL, Lilja A, Hartvig P, Langstrom B, Gordh T, Handwerker H, Torebjork E. Somatotopic organization along the central sulcus, for pain localization in humans, as revealed by positron emission tomography. Exp Brain Res. 1997 Nov;117(2):192-9. doi: 10.1007/s002210050215.
Reference Type
BACKGROUND
Lim ECW, Sterling M, Stone A, Vicenzino B. Central hyperexcitability as measured with nociceptive flexor reflex threshold in chronic musculoskeletal pain: a systematic review. Pain. 2011 Aug;152(8):1811-1820. doi: 10.1016/j.pain.2011.03.033. Epub 2011 Apr 27.
Reference Type
BACKGROUND
Fernandez-Carnero J, Ge HY, Kimura Y, Fernandez-de-Las-Penas C, Arendt-Nielsen L. Increased spontaneous electrical activity at a latent myofascial trigger point after nociceptive stimulation of another latent trigger point. Clin J Pain. 2010 Feb;26(2):138-43. doi: 10.1097/AJP.0b013e3181bad736.
Reference Type
BACKGROUND
Stifani N. Motor neurons and the generation of spinal motor neuron diversity. Front Cell Neurosci. 2014 Oct 9;8:293. doi: 10.3389/fncel.2014.00293. eCollection 2014.
Reference Type
BACKGROUND
Evans V, Koh RGL, Duarte FCK, Linde L, Amiri M, Kumbhare D. A randomized double blinded placebo controlled study to evaluate motor unit abnormalities after experimentally induced sensitization using capsaicin. Sci Rep. 2021 Jul 2;11(1):13793. doi: 10.1038/s41598-021-93188-7.
Reference Type
DERIVED
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MotorUnitsCapsaicin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
The Role of TRP Channels in CIPN
NCT04415892
RECRUITING
NA
Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort
NCT05817591
RECRUITING
Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
NCT00528216
COMPLETED
PHASE1
Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain
NCT01596491
COMPLETED
Capsaicin in Digital Osteoarthritis Versus Control
NCT06444919
RECRUITING
PHASE4
Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
NCT02441660
COMPLETED
NA
Pain Thresholds Under High-dose Topical Capsaicin
NCT02570841
COMPLETED
PHASE4
Cayenne Pepper Cataplasm - Effect Study
NCT02705209
COMPLETED
NA
Efficacy Study Comparing Compounded Topical Pain Creams vs. Placebo for Treating Pain Symptoms
NCT02497066
COMPLETED
PHASE3
Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain
NCT03189823
COMPLETED
Interaction Between NGF and Acute Exercise-induced Ischemia
NCT03470038
COMPLETED
EARLY_PHASE1
Capsaicin-Evoked Pain in Patients With CRPS
NCT00468390
COMPLETED
Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain
NCT00414349
COMPLETED
PHASE3
Cayenne Pepper Cataplasm - Safety Study
NCT03440125
COMPLETED
PHASE1/PHASE2
Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
NCT05840562
RECRUITING
PHASE3
A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin
NCT03587220
COMPLETED
NA
Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain
NCT02700815
COMPLETED
PHASE3
Double-blind Trial of Mannitol Cream to Block the Effect of Capsaicin Cream
NCT01963910
COMPLETED
NA
The Role of TRP Channels in DPN
NCT07237022
RECRUITING
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232
ACTIVE_NOT_RECRUITING
NA
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710
COMPLETED
PHASE2
Neuromodulation of Lidocaine and Capsaicin Cream Effects on Pain Experience
NCT03102710
COMPLETED
NA
Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment
NCT03348735
TERMINATED
PHASE4
Thermosensitivity of a Topical Palmitated Formulation of Capsaicin
NCT05649228
COMPLETED
EARLY_PHASE1
Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients
NCT01363284
COMPLETED
NA